Left ventricular hypertrophy in chronic uremia (a review)

Dialysis and Transplantation

Volumn 29, Issue 6, 2000, Pages 312-318

  Dyadyk, A I ^a   Bagriy, A E ^a   Yarovaya, N F ^a  

^a DONETSK MEDICAL UNIVERSITY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ANTIHYPERTENSIVE THERAPY; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; UREMIA;

EID: 0034042996     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RSC, Junor BJR, McMillan MA, Briggs JD. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transpl 1998; 13:1499-1505.
2. London GM, Fabiani F. Left ventricular dysfunction in end-stage renal disease: Echocardiographic insights. In: Cardiac Dysfunction in Chronic Uremia, Parfrey PS, Harnett JD (eds). Basel, Switzerland: Kluwer Academic Publishers, 1992, pp 117-137.
3. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36:286-290.
4. Agodoa LY, Eggers PW. Renal replacement therapy in the United States: Data from the United States Renal Data System. Am J Kidney Dis 1995; 25:119-133.
5. Valderrabano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transpl 1995; 10(Suppl 5):1-25.
6. Erturk S, Ertug AE, Ates K, Duman N, Asian SM, Nergisoglu G, Diker E, Erol C, Karatan O, Erbay B. Relationship of ambulatory blood pressure monitoring data to echocardiographic findings in haemodialysis patients. Nephrol Dial Transpl 1996; 11:2050-2054.
7. Kunz K, Dimitrov Y, Muller S, Chantrel F, Hannedouche T. Uraemic cardiomyopathy. Nephrol Dial Transpl 1998; 13(Suppl 4): 39-43.
8. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AEG, Baker LRI. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transpl 1997; 12:724-728.
9. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24:768-776.
10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PK. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5:2024-2031.
11. Cannella G. Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia. Int J Artif Organs 1998; 21:378-383.
12. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AEG, Baker LRI. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transpl 1997; 12:724-728.
13. Huting J, Kramer W, Schotterle G, Wizemann V. Analysis of left-ventricular changes associated with chronic haemodialysis. A non-invasive follow-up study. Nephron 1988; 49:284-290.
14. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease: Comparative effects on ACE-inhibition and calcium channel blockade. Circulation 1994; 90:2786-2796.
15. Vanrenterghem Y, Vanwallenghem J. Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietin. Nephrol Dial Transpl 1998; 13(Suppl 2):13-15.
16. Timio M. Cardiotoxicity of parathyroid hormone in chronic renal failure. Ital J Mineral Electrolyte Metab 1995; 9:19-24.
17. Amann K, Kronenberg G, Gehlen F, Wessels S, Orth S, Munter K, Ehmke H, Mall G, Ritz E. Cardiac remodelling in experimental renal failure: An immunohistochemical study. Nephrol Dial Transpl 1998; 13:1958-1966.
18. Cannella G, Paoletti E, Delfino R, Peloso G, Molinari S, Traverso GB. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy. Kidney Int 1993; 44:881-886.
19. Demuth K, Blacher J, Guerin AP, et al. Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transpl 1998; 13:375-383.
20. Wizemann V, Schafer R, Kramer W. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left ventricular hypertrophy. Nephron 1993; 64:202-206.
21. Zehnder C, Zuber M, Sulzer M, et al. Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialysed patients. Nephron 1992; 61:21-25.
22. Himelman RB, Lanzberg JS, Simonson JS, et al. Cardiac consequences of renal transplantation: Changes in left ventricular morphology and function. J Am Coll Cardiol 1988; 12:915-923.
23. Rambausek M, Mall G, Kollmar S, Ritz E. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia. Kidney Int 1988; 34(Suppl 25): 201-203.
24. Roithinger FX, Punzengruber C, Wallner M, et al. The influence of ACE-inhibition on myocardial mass and diastolic function in chronic hemodialysis patients with adequate control of blood pressure. Clin Nephrol 1994; 42:309-314.
25. Dyadyk AI, Bagriy AE, Lebed IA , Yarovaya NF, Schukina EV, Taradin GG. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure Nephrol Dial Transpl 1997; 12:945-951.